1. Адаскевич В.П. Акне вульгарные и розовые. М.: Медицинская книга; Н.
Новгород: Изд-во НГМА, 2003.
2. Breit R. Die periorale Dermatitis: Eine Therapeutische Herausforderung.
Plewig G, Wolff H (Hrsg.) Fortschritte der Praktischen Dermatologie und Venerologie.
Band 16. Berlin: Springer, 1999; s. 545–9.
3. Потекаев Н.Н., Аравийская Е.Р., Соколовский Е.В. и др. Акне и розацеа.
М.-СПб.: БИНОМ, 2007.
4. Lehmann P. Periorale Dermatitis. In: Plewig G, Kaudewitz P, Sander CA
(Hrsg) Fortschritte der praktischen Dermatologie und Venerologie. Bd 19.
Berlin: Springer, 2005; s. 515–7.
5. Schofer H. Rosazea: Klinik und aktuelle Therapie. Stuttgart: Georg Thieme
Verlag, 2003.
6. Boeck K, Abeck D, Werfel S, Ring J. Perioral dermatitis in children – clinical
presentation, pathogenesis-related factors and response to topical metronidazole.
Dermatology 1997; 195: 235–8.
7. Fritsch P, Pichler E, Linser I. Periorale Dermatitis. Hautarzt 1989; 40:
475–9.
8. Plewig G, Kligman AM, Jansen JJ. Acne and Rosacea. Berlin: Springer Verlag,
2000.
9. Олисова О.Ю., Громова С.А. Периоральный дерматит. Рус. мед. журн.
2003; 11 (17): 972–5.
10. Карелин О.Ю., Карелин Ю.М. Периоральный дерматит: лечение
азелаиновой кислотой. Клин. дерматол. и венерол. 2006; 1: 75–7.
11. Dirschka T, Tronnier H, Folster-Holst R. Clinical and Laboratory Investigations:
Epithelial barrier function and atopic diathesis in rosacea and perioral
dermatitis. Br J Dermatol 2004; 150: 1136–41.
12. Jansen T. Azelainsaure als neue Therapieoption bei perioraler Dermatitis.
Der Deutsche Dermatologie 2004; 7: 477–8.
13. Wollenberg A, Oppel T. Scoring of Skin Lesions with the Perioral Dermatitis
Severity Index (PODSI). Acta Dermato-Venereol 2006; 3 (86): 251–2.
14. Fonacier L, Spergel J, Charlesworth EN et al. Report of the Topical Calcineurin
Inhibitor Task Force of the American College of Allergy, Asthma, and
Immunology and the American Academy of Allergy, Asthma, and Immunology.
J Allergy Clin Immunol 2005; 115: 1249–53.
15. Ruzicka T, Assmann T, Lebwohl M. Potential future dermatological indications
for tacrolimus ointment. Eur J Dermatol 2003; 13: 331–42.
16. Skin Disease: Diagnosis and Treatment. Habif TP, Campbell JL, Chapman
MS et al. Philadelphia: Elsevier, 2005.
17. Rodriguez-Martin M, S?ez M, Camerero A et al. A new treatment for perioral
dermatitis. JEADV 2005; 19 (Suppl. 2): 975.
18. Schafer J, Jess P, Elshorst-Schmidt T et al. Successful treatment of rosaceiform
dermatitis in an infant with 1% Pimecrolimus cream. JEADV 2005;
19 (Suppl. 2): 828.
19. Wollenberg A, Pavicic T, Wetzel S et al. Pimecrolimus 1% cream is effective
in rosacea-like perioral dermatitis – results of a randomized, double-blinded,
vehicle controlled clinical trial involving 40 patients. JEADV 2005; 19
(Suppl. 2): 59.